購物車
幫助
021-54845833/15800441009
|
Background: |
Galactose-1-phosphate uridyl transferase (GALT) catalyzes the second step of the Leloir pathway of galactose metabolism, namely the conversion of UDP-glucose + galactose-1-phosphate to glucose-1-phosphate + UDP-galactose. The absence of this enzyme results in classic galactosemia in humans and can be fatal in the newborn period if lactose is not removed from the diet. The pathophysiology of galactosemia has not been clearly defined. Two transcript variants encoding different isoforms have been found for this gene. |
|
Applications: |
ELISA, WB, IHC |
|
Name of antibody: |
GALT |
|
Immunogen: |
Fusion protein of human GALT |
|
Full name: |
galactose-1-phosphate uridylyltransferase |
|
SwissProt: |
P07902 |
|
ELISA Recommended dilution: |
2000-5000 |
|
IHC positive control: |
Human tonsil and Human brain |
|
IHC Recommend dilution: |
50-200 |
|
WB Predicted band size: |
43 kDa |
|
WB Positive control: |
Human fetal liver tissue |
|
WB Recommended dilution: |
500-2000 |
